Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy

Published:2018-04-13 Issue:5 Volume:59 Page:723-725
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Tulchinsky Mark,Binse Ina,Campennì Alfredo,Dizdarevic Sabina,Giovanella Luca,Jong Ian,Kairemo Kalevi,Kim Chun K.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference12 articles.

1. Molenaar RJ Sidana S Radivoyevitch T . Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer. J Clin Oncol. December 18, 2017 [Epub ahead of print].

2. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

3. Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer

4. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

5. Cancer Risk After Iodine-131 Therapy for Hyperthyroidism

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern Diagnostic and Therapeutic Approaches in Thyroid Diseases: Theranostics and the Changing Role of Radioactive Isotopes;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

2. Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer;Seminars in Nuclear Medicine;2023-07

3. Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study;Current Oncology;2022-12-20

4. Estimating the Risk for Secondary Cancer After Targeted α-Therapy with²¹¹At Intraperitoneal Radioimmunotherapy;Journal of Nuclear Medicine;2022-07-07

5. Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with ¹³¹I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation;Journal of Nuclear Medicine;2022-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3